No results for ‘’
Astrazeneca Pharma India Ltd
₹6764.50
(1.40%)
Mon, 21 Sept 2026, 07:01 pm
Health Technology
Pharmaceuticals: Major
24.5KAstrazeneca Pharma India Share Price Live Chart
1 Day
(1.40%)
No Result Found
Summary
Market Cap (in Cr)
21678.63
Net Profit (in Cr)
115.74
P/B
27.93
Sector P/E
44.89
P/E
185.88
EV/EBITDA
106.24
Debt/Equity (Industry)
0.08
Interest Cover (Industry)
42.77
ROCE (Industry)
23.88
RONW (Industry)
19.04
ROE
23.63
ROCE
32.94
Debt/Equity
0.03
EPS (TTM)
76.57
Dividend Yield
0.42
Book Value
349.12
Interest Cover
174.17
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 75 | 75 | 75 | 75 | 75 |
| FII | 2.78 | 2.71 | 2.74 | 3.03 | 2.89 |
| DII | 5.80 | 5.56 | 5.26 | 4.56 | 4.65 |
| Public | 16.42 | 16.73 | 17.00 | 17.41 | 17.46 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 10665.50 | 9060.50 | 8006 | 7455.50 | 6401 | 5850.50 | 4245.50 |
| Fibonacci | 9060.50 | 8447.39 | 8068.61 | 7455.50 | 6842.39 | 6463.61 | 5850.50 |
| Camarilla | 7392.88 | 7245.75 | 7098.63 | 7455.50 | 6804.38 | 6657.25 | 6510.13 |
Pivots Level: Classic
R3
+3210
10665.50
R2
+1605
9060.50
R1
+550.50
8006
S1
-1054.50
6401
S2
-1605
5850.50
S3
-3210
4245.50
Moving Average
Period
Value
10-EMA
6777.40
20-EMA
6957.13
30-EMA
7132.62
50-EMA
7403.39
100-EMA
7790.35
200-EMA
8104.15
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 26 May 2026 | board-meetings | Accounts, Quarterly Results, Final Dividend | |
| 11 Feb 2026 | board-meetings | Quarterly Results | |
| 07 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results | |
| 28 Jul 2025 | agm | ||
| 18 Jun 2025 | dividend | Dividend - Rs. - 32 | 18 Jul 2025 |
| 30 May 2025 | dividend | ₹32.00 Dividend /Share | 18 Jul 2025 |
| 16 Jul 2024 | agm | ||
| 05 Jun 2024 | dividend | Final Dividend - Rs. - 24 | 05 Jul 2024 |
| 27 May 2024 | dividend | ₹24.00 Dividend /Share | 05 Jul 2024 |
| 22 Jul 2023 | agm |
Peer Comparison
Astrazeneca Pharma India Ltd
Cipla Ltd
Dr Reddys Laboratories Ltd
Divis Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Astrazeneca Pharma India Ltd About
Astrazeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinicaltrial services to an overseas group company.(Source : 202503-Annual Report Page No:148)
Industry
Pharmaceuticals - Multinational
Founded
1979
Headquarters
CEO
Shilpa Divekar Nirula
Employees
Contact
Website
http://www.astrazeneca.in
comp.secy@astrazeneca.com
Phone
91-080-67748000
Location
Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road, Bangalore, Karnataka, 560045
Astrazeneca Pharma India Ltd Company History
| Year | History |
|---|---|
| 2018 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 125166 | 7887.16 | 07 Oct 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 125166 | 7884.41 | 07 Oct 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 127119 | 7802 | 30 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 127119 | 7804.96 | 30 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 131308 | 7499.17 | 24 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 131308 | 7506.36 | 24 Sept 2024 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 74097 | 3152.55 | 19 Sept 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 6542 | 3152.55 | 19 Sept 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 6542 | 3152.55 | 19 Sept 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 74097 | 3152.55 | 19 Sept 2022 |
Frequently Asked Questions
1.What is the stock price of Astrazeneca Pharma India Ltd?
As of 22/09/2026 at 12:31 AM, Astrazeneca Pharma India Ltd shares are trading at ₹6764.50.
2.What is the market cap. of Astrazeneca Pharma India Ltd?
As of 22/09/2026, the market capitalization of Astrazeneca Pharma India Ltd is ₹16,963.38 crore.
3.When was Astrazeneca Pharma India Ltd founded?
Astrazeneca Pharma India Ltd was founded in 1979.
4.What are the P/E and P/B ratios of Astrazeneca Pharma India Ltd?
As of 22/09/2026, Astrazeneca Pharma India Ltd has a P/E ratio of 99.70 and a P/B ratio of 27.93.
5.How can I buy shares of Astrazeneca Pharma India Ltd?
You can buy shares of Astrazeneca Pharma India Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Astrazeneca Pharma India Ltd?
As of March,2026, promoters hold 75.00% in Astrazeneca Pharma India Ltd, while FIIs, DIIs and public shareholders hold 2.78%, 5.80% and 16.42%, respectively.
7.Does Astrazeneca Pharma India Ltd pay dividends?
Yes, Astrazeneca Pharma India Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Dividend - Rs. - 32 per share.
8.What is the dividend yield of Astrazeneca Pharma India Ltd?
As of 22 September, 2026, the dividend yield of Astrazeneca Pharma India Ltd stands at 0.53%.
9.What are the latest financial results of Astrazeneca Pharma India Ltd?
For January,2024, Astrazeneca Pharma India Ltd reported revenue of ₹1,716.00 crore and a net profit of ₹116.00 crore.
10.What is the Stock symbol of Astrazeneca Pharma India Ltd?
ASTRAZEN is the stock symbol of Astrazeneca Pharma India Ltd.
11.Who is the CEO of Astrazeneca Pharma India Ltd?
The CEO of Astrazeneca Pharma India Ltd is Shilpa Divekar Nirula.